Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT00182351
Eligibility Criteria:
Inclusion Criteria:
* first suspected deep vein thrombosis
* no previous venous thromboembolism
* referred to thromboembolism outpatient clinic
Exclusion Criteria:
* comorbid condition limiting survival to less than six months
* contraindication to venography (contrast allergy, etc.)
* receiving long term warfarin therapy
* receiving full dose heparin therapy for more than 48 hours
* absence of symptoms during the five days immediately prior to presentation
* symptoms of pulmonary embolism
* pregnancy
* geographic inaccessibility which precludes follow-up
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Study:
NCT00182351
Study Brief:
Protocol Section:
NCT00182351